Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic and sterilization process.
Inspection Record
Fresenius Kabi USA, LLC — FDA 483 Findings
Inspectors Mindy M ChouThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Verification of the suitability of the testing methods is deficient in that they are not performed under actual conditions of use.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Gland Pharma Limited2025-02-25 · US FDASimilar to finding 2 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Greer Laboratories, Inc.2024-12-18 · US FDASimilar to finding 2 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Shilpa Medicare Limited2026-05-29 · US FDASimilar to finding 2 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Apotek Production & Laboratorier AB2026-01-29 · US FDASimilar to finding 2 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Natco Pharma Limited2023-10-18 · US FDASimilar to finding 2 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.